Meeting of the National Advisory Council for Healthcare Research and Quality, 63497-63498 [2010-25774]
Download as PDF
<![CDATA[
Federal Register / Vol. 75, No. 199 / Friday, October 15, 2010 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Aging; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Aging Special Emphasis Panel; Genetic
Determinants of Healthy Aging.
Date: November 10, 2010.
Time: 1 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute on Aging,
Gateway Building, 7201 Wisconsin Avenue,
Suite 2C212, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Elaine Lewis, PhD,
Scientific Review Branch, National Institute
on Aging, Gateway Building, Suite 2C212,
MSC–9205, 7201 Wisconsin Avenue,
Bethesda, MD 20892, 301–402–7707,
elainelewis@nia.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, Aging Research,
National Institutes of Health, HHS)
Dated: October 8, 2010.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
General Medical Sciences Special Emphasis
Panel; Wound Healing Center Grant.
Date: November 9, 2010.
Time: 12 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Natcher Building, 45 Center Drive, Bethesda,
MD 20892 (Telephone Conference Call).
Contact Person: Meredith D. TempleO’Connor, PhD, Scientific Review Officer,
Office of Scientific Review, National Institute
of General Medical Sciences, National
Institutes of Health, 45 Center Drive, Room
3AN12C, Bethesda, MD 20892, 301–594–
2772, templeocm@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.375, Minority Biomedical
Research Support; 93.821, Cell Biology and
Biophysics Research; 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.862, Genetics and
Developmental Biology Research; 93.88,
Minority Access to Research Careers; 93.96,
Special Minority Initiatives, National
Institutes of Health, HHS)
Dated: October 8, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2010–26075 Filed 10–14–10; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Healthcare Research and
Quality
Meeting of the National Advisory
Council for Healthcare Research and
Quality
[FR Doc. 2010–26076 Filed 10–14–10; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Healthcare Research
and Quality (AHRQ), HHS.
ACTION: Notice of public meeting.
National Institutes of Health
SUMMARY:
AGENCY:
mstockstill on DSKH9S0YB1PROD with NOTICES
National Institute of General Medical
Sciences; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
VerDate Mar<15>2010
16:01 Oct 14, 2010
Jkt 223001
In accordance with section
10(a) of the Federal Advisory Committee
Act, 5 U.S.C. App. 2, this notice
announces a meeting of the National
Advisory Council for Healthcare
Research and Quality.
DATES: The meeting will be held on
Friday, November 5, 2010, from 8:30
a.m. to 3 p.m.
ADDRESSES: The meeting will be held at
the Eisenberg Conference Center,
Agency for Healthcare Research and
Quality, 540 Gaither Road, Rockville,
Maryland 20850.
PO 00000
Frm 00065
Fmt 4703
Sfmt 4703
63497
FOR FURTHER INFORMATION CONTACT:
Jaime Zimmerman, Coordinator of the
Advisory Council, at the Agency for
Healthcare Research and Quality, 540
Gaither Road, Rockville, Maryland,
20850, (301) 427–1456. For press-related
information, please contact Karen
Migdail at (301) 427–1855.
If sign language interpretation or other
reasonable accommodation for a
disability is needed, please contact the
Food and Drug Administration (FDA)
Office of Equal Employment
Opportunity and Diversity Management
on (301) 827–4840, no later than
October 22, 2010. The agenda, roster,
and minutes are available from Ms.
Bonnie Campbell, Committee
Management Officer, Agency for
Healthcare Research and Quality, 540
Gaither Road, Rockville, Maryland,
20850. Ms. Campbell’s phone number is
(301) 427–1554.
SUPPLEMENTARY INFORMATION:
I. Purpose
The National Advisory Council for
Healthcare Research and Quality was
established in accordance with Section
921 (now Section 941) of the Public
Health Service Act, 42 U.S.C. 299c. In
accordance with its statutory mandate,
the Council is to advise the Secretary of
the Department of Health and Human
Services and the Director, Agency for
Healthcare Research and Quality
(AHRQ), on matters related to AHRQ’s
conduct of its mission including
providing guidance on (A) priorities for
health care research, (B) the field of
health care research including training
needs and information dissemination on
health care quality and (C) the role of
the Agency in light of private sector
activity and opportunities for public
private partnerships. The Council is
composed of members of the public,
appointed by the Secretary, and Federal
ex-officio members specified in the
authorizing legislation.
II. Agenda
On Friday, November 5, there will be
a subcommittee meeting for the National
Healthcare Quality and Disparities
Report scheduled to begin at 7:30 a.m.
The Council meeting will convene at
8:30 a.m., with the call to order by the
Council Chair and approval of previous
Council summary notes. The AHRQ
Director will present her update on
current research, programs, and
initiatives. The agenda will include
discussions on Operationalizing the
National Quality Strategy and AHRQ’s
role in Operationalizing the National
Health Quality Strategy. The final
agenda will be available on the AHRQ
E:\FR\FM\15OCN1.SGM
15OCN1
63498
Federal Register / Vol. 75, No. 199 / Friday, October 15, 2010 / Notices
Web site at https://www.ahrq.gov no later
than November 1, 2010.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Dated: October 5, 2010.
Carolyn M. Clancy,
Director.
National Institutes of Health
National Center for Complementary
and Alternative Medicine; Notice of
Closed Meeting
[FR Doc. 2010–25774 Filed 10–14–10; 8:45 am]
BILLING CODE 4160–90–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Eunice Kennedy Shriver National
Institute of Child Health & Human
Development; Notice of Closed
Meeting
mstockstill on DSKH9S0YB1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Child Health and Human Development
Special Emphasis Panel; Congenital
Diaphragmatic Hernia.
Date: November 9, 2010.
Time: 2 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6100
Executive Boulevard, Rockville, MD 20852
(Telephone Conference Call).
Contact Person: Neelakanta Ravindranath,
PhD, Scientific Review Officer, Division of
Scientific Review, Eunice Kennedy Shriver
National Institute of Child Health and
Human Development, NIH, 6100 Executive
Blvd., Room 5B01G, Bethesda, MD 20892,
301–435–6889, ravindrn@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.864, Population Research;
93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation
Research; 93.209, Contraception and
Infertility Loan Repayment Program, National
Institutes of Health, HHS)
Dated: October 6, 2010.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2010–26029 Filed 10–14–10; 8:45 am]
BILLING CODE 4140–01–P
VerDate Mar<15>2010
16:01 Oct 14, 2010
Jkt 223001
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Center for
Complementary and Alternative Medicine
Special Emphasis Panel; Clinical Review of
R01s.
Date: October 26, 2010.
Time: 11 a.m. to 1 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892 (Telephone
Conference Call).
Contact Person: Hungyi Shau, Scientific
Review Officer, National Center for
Complementary and Alternative Medicine,
National Institutes of Health, 6707
Democracy Boulevard, Suite 401, Bethesda,
MD 20892, 301–402–1030,
Hungyi.Shau@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.213, Research and Training
in Complementary and Alternative Medicine,
National Institutes of Health, HHS)
Dated: October 5, 2010.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2010–26026 Filed 10–14–10; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse;
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
PO 00000
Frm 00066
Fmt 4703
Sfmt 4703
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable materials,
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel;
Statistical Analysis in Support of DPMC
Clinical Trials (8894).
Date: October 27–28, 2010.
Time: 9 a.m. to 5 p.m.
Agenda: To review and evaluate contract
proposals.
Place: Courtyard by Marriott Rockville,
2500 Research Boulevard, Rockville, MD
20850.
Contact Person: Lyle Furr, Contract Review
Specialist, Office of Extramural Affairs,
National Institute on Drug Abuse, NIH,
DHHS, Room 220, MSC 8401, 6101 Executive
Boulevard, Bethesda, MD 20892–8401, (301)
435–1439, lf33c.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos.: 93.279, Drug Abuse and
Addiction Research Programs, National
Institutes of Health, HHS)
Dated: October 6, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2010–26024 Filed 10–14–10; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Healthcare Research and
Quality
Patient Safety Organizations:
Voluntary Delisting
Agency for Healthcare Research
and Quality (AHRQ), HHS.
ACTION: Notice of delisting.
AGENCY:
AHRQ has accepted a
notification of voluntary relinquishment
from the ACCE Healthcare Technology
Foundation of its status as a Patient
Safety Organization (PSO). The Patient
Safety and Quality Improvement Act of
2005 (Patient Safety Act), Public Law
109–41, 42 U.S.C. 299b–21–b–26,
provides for the formation of PSOs,
which collect, aggregate, and analyze
confidential information regarding the
quality and safety of health care
delivery. The Patient Safety and Quality
Improvement Final Rule (Patient Safety
Rule), 42 CFR part 3, authorizes AHRQ,
on behalf of the Secretary of HHS, to list
as a PSO an entity that attests that it
meets the statutory and regulatory
SUMMARY:
E:\FR\FM\15OCN1.SGM
15OCN1
]]>Agencies
[Federal Register Volume 75, Number 199 (Friday, October 15, 2010)]
[Notices]
[Pages 63497-63498]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-25774]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Agency for Healthcare Research and Quality
Meeting of the National Advisory Council for Healthcare Research
and Quality
AGENCY: Agency for Healthcare Research and Quality (AHRQ), HHS.
ACTION: Notice of public meeting.
-----------------------------------------------------------------------
SUMMARY: In accordance with section 10(a) of the Federal Advisory
Committee Act, 5 U.S.C. App. 2, this notice announces a meeting of the
National Advisory Council for Healthcare Research and Quality.
DATES: The meeting will be held on Friday, November 5, 2010, from 8:30
a.m. to 3 p.m.
ADDRESSES: The meeting will be held at the Eisenberg Conference Center,
Agency for Healthcare Research and Quality, 540 Gaither Road,
Rockville, Maryland 20850.
FOR FURTHER INFORMATION CONTACT: Jaime Zimmerman, Coordinator of the
Advisory Council, at the Agency for Healthcare Research and Quality,
540 Gaither Road, Rockville, Maryland, 20850, (301) 427-1456. For
press-related information, please contact Karen Migdail at (301) 427-
1855.
If sign language interpretation or other reasonable accommodation
for a disability is needed, please contact the Food and Drug
Administration (FDA) Office of Equal Employment Opportunity and
Diversity Management on (301) 827-4840, no later than October 22, 2010.
The agenda, roster, and minutes are available from Ms. Bonnie Campbell,
Committee Management Officer, Agency for Healthcare Research and
Quality, 540 Gaither Road, Rockville, Maryland, 20850. Ms. Campbell's
phone number is (301) 427-1554.
SUPPLEMENTARY INFORMATION:
I. Purpose
The National Advisory Council for Healthcare Research and Quality
was established in accordance with Section 921 (now Section 941) of the
Public Health Service Act, 42 U.S.C. 299c. In accordance with its
statutory mandate, the Council is to advise the Secretary of the
Department of Health and Human Services and the Director, Agency for
Healthcare Research and Quality (AHRQ), on matters related to AHRQ's
conduct of its mission including providing guidance on (A) priorities
for health care research, (B) the field of health care research
including training needs and information dissemination on health care
quality and (C) the role of the Agency in light of private sector
activity and opportunities for public private partnerships. The Council
is composed of members of the public, appointed by the Secretary, and
Federal ex-officio members specified in the authorizing legislation.
II. Agenda
On Friday, November 5, there will be a subcommittee meeting for the
National Healthcare Quality and Disparities Report scheduled to begin
at 7:30 a.m. The Council meeting will convene at 8:30 a.m., with the
call to order by the Council Chair and approval of previous Council
summary notes. The AHRQ Director will present her update on current
research, programs, and initiatives. The agenda will include
discussions on Operationalizing the National Quality Strategy and
AHRQ's role in Operationalizing the National Health Quality Strategy.
The final agenda will be available on the AHRQ
[[Page 63498]]
Web site at https://www.ahrq.gov no later than November 1, 2010.
Dated: October 5, 2010.
Carolyn M. Clancy,
Director.
[FR Doc. 2010-25774 Filed 10-14-10; 8:45 am]
BILLING CODE 4160-90-M
